What is Fetal Hydantoin Syndrome

Fetal Hydantoin Syndrome (FHS) is a condition that occurs when a pregnant woman takes hydantoin medications, such as phenytoin, to manage seizures or other medical conditions. These medications can cross the placenta and affect the developing fetus.

FHS can lead to various physical and developmental abnormalities in the affected child. Some common features include distinctive facial characteristics like a broad nose bridge, wide-set eyes, and a thin upper lip. Additionally, individuals with FHS may experience growth deficiencies, intellectual disabilities, learning difficulties, and delayed motor skills.

The severity of FHS can vary from person to person, with some individuals experiencing mild symptoms while others may have more significant impairments. Early diagnosis and intervention are crucial in managing the condition and providing appropriate support and therapies.

It is important for pregnant women to consult with their healthcare providers before taking any medications to ensure the potential risks and benefits are carefully evaluated. Alternative treatments or adjustments to medication dosage may be considered to minimize the risk of FHS.